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LABORATORY INVESTIGATION
Effect of furosemide administration on glomerular and tubular
dynamics in the rat
BRYAN J. TUCKER and ROLAND C. BLANTZ
University of California, San Diego, School of Medicine, and The Veterans Administration Medical Center, San Diego. Cal jfornia
Effect of furosemide administration on glomerular and tubular dynam-
ics in the rat. Furosemide, a potent diuretic, has also been shown (1)
to inhibit or reduce tubuloglomerular feedback activity, (2) act as a
vasodilatory agent, and (3) exhibit a modest carbonic anhydrase inhibi-
tory effect, which could potentially reduce proximal tubule reabsorp-
tion. If furosemide can inhibit tubuloglomerular feedback as well as
cause vasodilation, then glomerular filtration rate (GFR) should in-
crease through alterations in the dynamics of glomerular ultrafiltra-
tion. The effect of acute furosemide infusion (4 mg/kg of body wt per
hour) on glomerular and tubular dynamics was examined in Munich-
Wistar rats by two protocols: The first allowed a 3% volume depletion
(based on body wt) to occur as a result of furosemide administration
(group 1); the second allowed a complete replacement of volume after
furosemide administration (group 2). The results demonstrated that
when volume status was maintained after furosemide administration,
the nephron filtration rate remained constant (35 3 vs. 33 2 nI/mm,
NS) despite a twofold increase in distal flow rate (5 1 vs. 10 1
ni/mm, P < 0.01), indicating an inhibition or suppression of the tubulo-
glomerular feedback system. With either protocol, furosemide admin-
istration did not alter total nephron vascular resistance and nephron
blood flow (190 17 vs. 200 15 mI/mm); however, the afferent ar-
teriolar resistance did decrease in rats in which volume status was
maintained. Finally, with volume status maintained, we were not able
to demonstrate a reduction in absolute proximal fluid reabsorption de-
spite a 7 mm Hg increase in interstitial hydrostatic pressure (4 1 to
11 1 mm Hg, P < 0.01) and no compensatory increase in interstitial
oncotic pressure. These data indicate that tubuloglomerular feedback
was inhibited but that GFR was not increased. Major changes oc-
curred in interstitial pressures and interstitial volume after furosemide
administration, but absolute proximal reabsorption remained constant.
Effet de l'administration de furosemide sur Ia dynamique glomerulaire
et tubulaire chez le rat. Le furosémide, un diurétique puissant, peut
également (1) inhiber ou réduire l'activité du rétro-contrôle tubulo-
glomerulaire, (2) se comporter comme un agent vasodilatateur, et (3)
montrer un effet inhibiteur modeste de l'anhydrase carbonique, qui
pourrait réduire la reabsorption tubulaire proximale. Si le furosémide
peut inhiber le rétro-contrôle tubulo-glomérulaire et entrainer une
vasodilatation, alors le debit de filtration glomérulaire (GFR) devrait
s'élever en raison des alterations de Ia dynamique de l'ultrafiltration
glomerulaire. Les effets d'une perfusion aigue de furosémide (4 mg/kg
poids par hr) sur Ia dynamique glomCrulaire et tubulaire ont été
examines grace a deux protocoles chez des rats Munich-Wistar:
depletion de 3% du volume corporel par administration de furosémide
(groupe 1), et correction complete de Ia volémie aprés furosémide
(groupe 2). Les résultats demontrent que quand La volémie a été main-
tenue apres administration de furosémide, Ia filtration nephronique re-
stait constante (35 3 contre 33 2 nI/mm, NS) malgré un double-
ment du debit distal (5 I contre 10 1 nI/mm, P < 0,01), ce qui
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indique une inhibition ou une suppression du système de rétro-contrOle
tubulo-glomerulaire. Avec l'un ou l'autre protocole, l'administration de
furosémide n'a altCré ni Ia résistance vasculaire totale néphronique ni
le debit sanguin nephronique (190 17 contre 200 15 mI/mm); de
quelque manière la résistance arteriolare afferente a descendu chez les
rats chez que Ia voléniie était maintenue. Finalement, en maintenant
Ia volémie, nous n'avons pas Pu démontrer de reduction de La
reabsorption proximale absolue de liquides malgré une élévation de 7
mm Hg de Ia pression hydrostatique interstitielle (de 4 1 a 11 1
mm Hg, P < 0,01), et l'absence d'élévation compensatrice de Ia pres-
sion oncotique interstitielle. Ces données indiquent que le rétro-
contrôle tubulo-glomerulaire était inhibé mais que Ia filtration
glomérulaire n'était pas augmentée. Modifications majeures se sont
produites dans les pressions interstitielles et le volume interstitiel aprCs
administration de furosémide, mais Ia reabsorption proximale absolue
est restée constante.
Furosemide is one of the most commonly used drugs in clini-
cal medicine today. Its primary mechanism of action is the in-
hibition of sodium chloride transport in the ascending limb of
the ioop of Henle, which decreases fluid and electrolyte reab-
sorption and increases flow to distal portions of the nephron.
Previous studies have shown, however, that furosemide admin-
istration can also affect other processes. First, it has been
shown to reduce or inhibit tubuloglomerular feedback activity
[1, 21. This, in turn, should lead to increases in nephron filtra-
tion rate through increases in blood flow and/or changes in
glomerular hydrostatic pressure via decreases in afferent or ef-
ferent arteriolar resistance or both. Second, it has been shown
by several studies to function as a vasodilatory agent [3—81 in
the renal vasculature, which may be the result of either inhi-
bition of tubuloglomerular feedback or through a direct effect
of furosemide itself. This vasodilatory response should also al-
ter the forces for glomerular ultrafiltration and tubular reab-
sorption. Third, furosemide administration could potentially in-
crease renal interstitial pressure and has been shown to dem-
onstrate a modest effect as a carbonic anhydrase inhibitor [9,
10], and both of these effects should act to reduce proximal tu-
bule fluid reabsorption. Its potential for direct vasodilation and
inhibition of tubuloglomerular feedback activity and for modi-
fications of proximal tubule fluid reabsorption should increase
both glomerular filtration rate (GFR) and fluid delivery into the
loop of Henle. These potential effects should increase the èf-
ficacy of this agent as a diuretic and thereby alter the renal con-
trol of volume homeostasis. However, previous studies have
shown either a decrease or no change in GFR [1, 7, 8, 11, 121.
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it is possible that the volume losses that occurred as a result
of the diuresis may have counteracted the primary postulated
effects of furosemide regarding feedback control of glomerular
ultrafiltration and tubular reabsorption. This study therefore
examines the effect of furosemide on glomerular dynamics and
tubular fluid reabsorption in a setting in which there is no
change in volume status of the rat.
The determinants of glomerular ultrafiltration are examined
by the use of two experimental protocols: (1) one in which rats
receiving furosemide are allowed to become volume-depleted
(a loss of 3% of their body wt) from acute urinary losses; and
(2) one in which rats receiving furosemide are given complete
replacement of urinary volume losses. We studied the evi-
dence that systemic furosemide administration results in inhi-
bition of tubuloglomerular feedback activity and the effects of
this inhibition on nephron filtration rate and glomerular hemo-
dynamics. We also examined the effects of furosemide on ab-
solute proximal reabsorption and interstitial hydrostatic and
oncotic pressures, as well as an index of interstitial volume to
ascertain the impact of interstitial forces on proximal tubule
fluid reabsorption.
Methods
Experiments were performed on male Munich-Wistar rats
that had a weight range of 215 to 295 g at the time of the study.
The animals had been bred and maintained in an isolated
colony housed at the San Diego Veterans Administration Medi-
cal Center, San Diego, California. On the day the study began,
the rats were anesthetized with mactin (100 mg/kg of body wt,
i.p.). A tracheostomy was performed (PE-240), and PE-50 cath-
eters were placed in the left jugular vein, left femoral artery,
bladder, and left ureter. Arterial blood pressure was mon-
itored continuously throughout the studies with a P23dB
Gould-Statham (Oxnard, California) pressure transducer and
recorded on a Statham chart recorder. Body temperature was
regulated by a heated table with a servo-controlled heating
unit. Further surgical preparation for rat micropuncture was
performed by previously described methods [131. An infusion
of '4C-inulin at a rate of approximately 50 tCi/hr was initiated
60 mm prior to the first micropuncture measurements and was
continued throughout the remainder of the study as a marker
of glomerular ultrafiltration.
Micropuncture studies in volume-depleted rats (group 1, N
= 6). An infusion of an isotonic solution of sodium chloride
and sodium bicarbonate was maintained throughout the surgi-
cal preparation and the control measurement period at a rate
of approximately 0.6% of body wt per hour. All measurements
of glomerular, tubular, postglomerular, peritubular capillary,
and interstitial hydrostatic pressures were obtained in the
hydropenic period. Timed collections of tubular fluid were per-
formed in a paired fashion at both late proximal and early dis-
tal sites, localized by the tubular injection of FD&C green dye,
to measure the single nephron filtration rate (SNGFR) and the
tubular fluid-to-plasma (TF/P) inulin concentration ratios. At
least four paired proximal and distal samples were obtained.
Efferent arteriolar (or large peritubular capillary) blood sam-
ples (at least three) were collected for determination of protein
concentration. All these measurements were obtained within
approximately 60 mm. Samples of blood (100 1d) were col-
lected for determining plasma sodium and potassium concen-
trations. After the completion of these initial measurements, a
bolus dose of furosemide (4 mg/kg of body wt; Lasix,
Hoechst-Roussel Pharmaceuticals Inc., Somerville, New Jer-
sey) was administered i.v., followed by a continuous furose-
mide infusion (4 mg/kg of body wt per hour). Volume replace-
ment was not performed until 3% of the rat's body weight had
been lost through urinary excretion. After the 3% loss, an iso-
tonic solution of sodium chloride and sodium bicarbonate was
infused i.v. to replace the urinary losses, and all measure-
ments were repeated.
Micropuncture studies in volume-replaced rats (group 2; N
6). The same procedures followed for group 1 were also
used for group 2 except that urinary losses were replaced, at a
matching infusion rate, with isotonic sodium chloride and so-
dium bicarbonate. After a 20-mm stabilization period, all meas-
urements were repeated.
Measurement of subcapular protein concentration (group 3;
N = 4). An infusion of isotonic sodium chloride and sodium
bicarbonate was maintained throughout the surgical prepara-
tion and the control measurement period at a rate of approxi-
mately 0.6% of body wt per hour. The kidney was placed in a
cup, and the cup was sealed with cotton and agar. Mineral oil
was suffused over the exposed surface of the kidney at the site
where the subcapsular fluid was to be collected. An oil-filled
glass pipette (6 to 9 jtm) was inserted immediately beneath the
kidney capsule at a shallow angle usually adjacent to a pen-
tubular capillary. With any evidence of bleeding or puncturing
a tubule, a new collection site was located. Usually, three col-
lections were performed with a collection time of 20 to 40 mm.
Gentle aspiration sufficient to obtain 60 to 80 nl was used. Af-
ter completion of these measurements, a bolus dose of furo-
semide (4 mg/kg) was administered i.v., followed by a continu-
ous furosemide infusion (4 mg/kg/hr). Urinary losses were re-
placed at a matching infusion rate, with isotonic sodium chlo-
ride and sodium bicarbonate. After a 20-mm stabilization pe-
riod, the subcapsular collections were repeated.
Determination of renal interstitial volume index (group 4; N
= 8). This group of rats was divided into two subgroups, a con-
trol hydropenic group (N = 4) and a volume-replete group (N
= 4) similar to group 2. An isotonic solution of sodium chlo-
ride and sodium bicarbonate was infused throughout the sur-
gical preparation at a rate of approximately 0.6% of body wt
per hour. Littermate red blood cells were labeled with 51Cr ac-
cording to the method described by Sterling [14] and Sterling
and Gray [151 for measurement of vascular space. Human se-
rum albumin (E. R. Squibb & Sons, Inc., Princeton, New Jer-
sey) labeled by 1251 was used both as a plasma volume marker
and, after a period of 60 mm, as an index of renal interstitial
space. At the end of the stabilization period in hydropenia or
furosemide administration, I ml of labeled red blood cells and
rat plasma containing the labeled human serum albumin (HSA)
was infused i.v. Within 5 mm of the infusion, a 200-pi femoral
arterial blood sample was obtained for red cell and plasma vol-
ume determination. Sampling was continued at 15-mm inter-
vals for a 60-mm period to determine the equilibration of HSA
into extravascular spaces. At the end of the equilibration pe-
riod, the renal vasculature was double-clamped, and the kid-
ney was excised and immediately immersed in liquid nitrogen
to snap-freeze the tissue. After the kidney was frozen, three to
four sections of renal cortical tissue were obtained and placed
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in separate counting vials, as was the remnant kidney, and
counted on a gamma counter and compared to whole blood
counts taken at the same time.
Analytical methods. Total filtration rates were calculated as
previously described [13]. Carbon-14 counts in plasma, urine,
and tubular fluid were monitored on a scintillation counter
(model 2425, Packard Instrument Co., Downer's Grove, Illi-
nois). Pressure measurements were obtained with a servo-nul-
ling device and glass-tip pipettes (1 to 3 m) [161. Pressure
measurements were recorded in glomerular capillaries,
Bowman's space, proximal tubules, interstitial spaces, and
along the length of the peritubular capillaries as previously de-
scribed [13, 17]. Calculation of absolute proximal reabsorption
(APR) and fractional reabsorption was done also as previously
described [17, 18]. The absolute loop-of-Henle tubular reabsorp-
tion, distal tubule flow rate, and late proximal tubule flow rate
(LPFR) were calculated as previously described [19]. SNGFR
refers to that value defined by distal tubule collections unless
otherwise designated.
Systemic plasma protein concentration was determined by
analysis of femoral artery blood. Efferent arteriolar protein
concentration was obtained from "star" vessels on the kidney
surface. Interstitial fluid protein concentration was obtained
from collections of subcapsular fluid as described previously
from this laboratory [18], which is a modification of the tech-
nique described by Wolgast et al [20]. All protein collections
were then analyzed by a microadaption [21] of the method of
Lowry et a! [22] as previously described by this laboratory [13].
Interstitial or subcapsular fluid samples were measured for pro-
tein concentration by the same assay used for other protein
samples except that the samples of this fluid were obtained
with a 21-ni constant-volume pipette, and the protein concen-
tration was determined from standard curves using 7-nl pi-
pettes with the appropriate volume correction. Oncotic pres-
sure of systemic protein samples (CA) and efferent arteriolar
samples (CE) were determined by the following relationship:
= l.74C + 0.28C2
which is a simplification of the empirical relationship defined
by Landis and Pappenheimer [23],
= 2.1C + 0.16C2 + 0.009C3
The equation defines the relationship between oncotic pres-
sure and protein concentrations during normal conditions when
approximately 50% of the total protein is albumin. The albu-
min-to-globulin (A/G) ratio of the interstitial fluid was deter-
mined from collections of renal lymph in a previous study from
our laboratory [24]. From these collections the A/G ratio was
2:1, and this ratio was assumed to be the same for interstitial
and subcapsular fluid. The relationships derived by Landis and
Pappenheimer [23] for oncotic pressure and protein concentra-
tions were used to derive the following equation for interstitial
oncotic pressure [18, 24]:
ir = 2.4C + 0.17C2 + 0.01C3
SNPF SNGFRI(1 CA/CE) (4)
where CA is the systemic and CE is the "star" peritubular pro-
tein concentration.
Single nephron blood flow (SNBF) was determined from the
following relationship:
SNBF = SNPF/(l — Hct) (5)
where Hct is the systemic hematocrit expressed as a fraction
of one. Plasma flow at the beginning of the peritubular capil-
lary system (SNPFE) was calculated by
SNPFE SNPF — SNGFR (6)
Afferent and efferent arteriolar resistances were calculated
as previously described [13].
Post-efferent arteriolar resistance (DR) was determined by
the following equation:
DR = [(HPE — HP)/(SNBF — SNGFR + 1/2 APR)] +
[HP5 — HPv)/SNBF] (7)
where HP5 is the hydrostatic pressure in the small (tertiary or
greater branch point) peritubular capillary and HPv is renal
vein pressure (assumed to be 3 mm Hg).
The determinant of absolute reabsorption from the intersti-
tial space into the peritubular capillary is defined as
APR = ERP LPAR (8)
where ERP represents the mean effective reabsorption pres-
sure across the peritubular capillary and LPAR is the peritubu-
lar capillary reabsorptive permeability coefficient. The ERP
along the peritubular capillary length (x*; where x* = x/L, with
L being capillary length) is described as
ERP = (ircx. — HP.) — (iT — HPI) (9)
where ir,. is the intracapillary hydrostatic pressure at the point
x, and ir and HP1 are the respective subcapsular oncotic and
hydrostatic pressures. The ERP is defined in the following
(1) equation
= f'o (ire — HPC) dx* — (ir1 — HP1) = f'0 ERP dx* (10)
The ERP curve and LpAr are determined by an iterative pro-
(2) cedure as described previously from this laboratory [17].
There is difficulty in assessing the peritubular capillary per-
meability coefficient (LpAr) because the peritubular capillary
network is a diffuse system which introduces error in normal
capillary pressure. Also, in this study we used only the APR
as the amount of fluid taken up by the peritubular capillaries
and did not include the contribution that may take place from
the pars recta and the distal tubule.
The determinants of SNGFR are defined as SNFGR = L1,A
where LA represents the glomerular permeability co-
efficient and •P is the mean effective filtration pressure
across the glomerular capillary. EFP along the glomerular cap-
illary length (x*) is described as
(3)
Plasma and urinary sodium and potassium concentrations were
determined by flame photometer (Instrumentation Laborato-
ries, Inc., Lexington, Massachusetts).
Calculations. Single nephron plasma flow (SNPF) was cal-
culated from the following relationships:
EFP = ( P —
The equation is defined in the following equation
EFP = f'o( P — ir) dx = f'o EFP dx
(11)
(12)
The EFP. curve and LpA were determined by an iterative pro-
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cedure as described previously from this laboratory [25]. At fil-
tration pressure equilibrium (lIE = as has been demon-
strated previously in the hydropenic Munich-Wistar rat
[25—271, a specific numerical value for LpA and EFP cannot be
defined; only a minimal value for LpA and a maximal value for
EFP can be defined.
Calculations for interstitial volume index are based on the es-
cape of '251-HSA (human serum albumin) from vascular space
into interstitium over 60 mm, at which time equilibration is
reached in rats [28, 291.
Blood volume (BV) in each renal cortical tissue sample was
determined by the following equation.
51Cr cpm in tissueBV/tissue sample = (13)
51Cr cpm/.d of systemic blood
where the hematocrit utilized for a microliter of systemic blood
is the uncorrected measured systemic hematocrit. This hema-
tocrit value is an overestimate of systemic hematocrit; true sys-
temic hematocrjt was determined to be 96% of the uncorrected
hematocrit. 125j counts in extravascular space (ES) were de-
termined by the following equation:
ES 125j cpm = total tissue
1251 cpm — (BV 1251 cpm4d of blood)
cant change (1.1 0.06 in control vs. 1.1 0.07 ml/min after
furosemide; NS). In group 1, urine flow increased from 2 1
(control) to 21 4 d/min. It increased in group 2 from 2 1
(control) to 84 7 sl/min. In group 1, the mean arterial pres-
sure decreased from 118 3 (control) to 100 3 mm Hg (P
<0.01), and it decreased in group 2 from 114 3 (control) to
106 2 mm Hg (P < 0.01). The hematocrit increased in group
1 from 56 1 (control) to 59 1% (P < 0.01), but it remained
unchanged in group 2 at 55 1%. The urinary sodium and po-
tassium excretion significantly increased in both groups I and
2. In group 1, sodium excretion increased from 0.06 0.01
(control) to 2.1 0.4 sEq/min (P < 0.01), and potassium ex-
cretion increased from 0.3 0.1 control to 1.0 0.1 sEq/min
(P <0.01). Group 2 sodium excretion increased from 0.09
0.01 (control to 15.2 3.5 sEq/min (P < 0.01), and potassium
excretion increased from 0.4 0.1 (control) to 2.7 0.7
Eq/min (P < 0.01).
Effect offurosemide on tubuloglornerular feedback. Single
nephron filtration rate (SNGFR) collected from distal tubule
sites was interpreted as the most accurate assessment of neph-
ron filtration rate. In group 1, distal flow rate (DFR) in control
was 6 1 nl/min (Table 1) with an SNGFR of 28 2 nI/mm.
After administration of furosemide and subsequent volume de-
pletion, DFR remained unchanged (5 1 nllmin, Table 1),
whereas SNGFR decreased significantly to 20 1 nl/min (P <
0.05). In group 2, SNGFR remained constant despite a dou-
bling of distal flow rate from 5 ito 10 1 nl/min (P <0.05,
Table 2). These data from group 2 indicate that increases in
flow to the distal portions of the nephron, normally a stimulus
to reduce SNGFR, did not significantly decrease the SNGFR
or the single nephron blood flow (SNBF) after furosemide ad-
ministration (Table 2).
SNGFR was measured in a paired fashion from both distal
and late proximal sites in both groups 1 and 2. The effect of fu-
rosemide administration on SNGFR in both groups is depicted
in Figure 1. In group 1, SNGFR values for both distal and late
proximal sites decreased significantly after furosemide admin-
istration and 3% body weight volume depletion. In group 2, the
distally determined SNGFR remained unchanged after furose-
mide administration (30 3 to 31 2 nl/min; control vs. fu-
rosemide administration, NS), and late proximal collections of
SNGFR were 35 3 in control and 33 2 nl/min after furo-
semide administration.
Figure 2 depicts the inhibition of proximal-distal collection
differences in nephron filtration rate following the administra-
tion of furosemide in both 3% body weight volume depletion
(group 1) and urinary replacement (group 2). Since the control
periods for both groups followed the same protocol, all control
SNGFRs (the proximal collection minus the distal collection)
were combined as one group (N = 51). The LSNGFR was sig-
nificantly different from zero at 4.8 1.4 ni/mm (P < 0.01) in
the controls; however, it was not different from zero in either
group after furosemide administration (Fig. 2). These data in-
dicate an inhibition or resetting of tubuloglomerular feedback
activity after furosemide administration.
Effects of furosemide on dynamics of glomerular ultrafiltra-
tion. The effect of furosemide administration on glomerular
dynamics in both groups I and 2 is shown in Table 3. In group
1 there was no significant change in glomerular pressure (Ps)
after furosemide administration. Although this group showed a
(14)
Because '25I-albumin should distribute in plasma and renal in-
terstitium in the same ratio as does endogenous albumin, we
determined the interstitial volume (Int V) in each tissue sam-
ple in the following manner:
'NT V = (ES 125! cpm/1251 cpm/sl of plasma)
plasma albumin cone.
interstitial albumin conc.
Interstitial albumin concentration was determined from the in-
terstitial protein concentration in group 3 rats and the previ-
ously determined renal interstitial A/G ratio [241. To determine
a percentage value of renal interstitial space, we used the fol-
lowing relationship:
% Interstitial volume (index) = 'NT V/wet tissue wt (16)
This percentage value should be viewed as an index of inter-
stitial volume and not necessarily as an accurate determination
of interstitial volume.
Statistical analysis. Significance of data between control and
experimental conditions was determined by analysis of vari-
ance and paired Student's t test where appropriate [30, 31].
Comparisons between groups were analyzed by unpaired t test
to determine significant differences. All data values are given
as the means SEM [301.
Results
Effect of furosemide administration during 3% body wt vol-
ume depletion (group I) and urinary replacement (group 2). In
both groups 1 and 2, comparisons were made between the con-
trol period (before furosemide administration) and the period
following its administration (that is, during volume depletion or
volume repletion). All measurements were made in the left
kidney.
In group 1, GFR decreased from 0.97 0.04 (control) to
0.66 0.02 ml/min (P < 0.01); in group 2 there was no signifi-
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Table 1. Effect of furosemide on tubular, interstitial, and peritubular capillary dynamics in volume-depleted rats (group 1) and in volume-
replaced rats (group 2)ab
-
SNGFR APR LPFR ALR DFR P i1 HP1 HP HP5
LpAr
nl/sec mm Hgni/mm mm Hg
Group 1
Control 28 13 15 9 6 13 35 4.6" 4 18 12 Il 0.020
Furosemide 20* 10* 10* 5* 5 11* 34 4.6" 4 16 11 10 0.018
Group 2
Control 29 14 15 10 5 13 32 4.6" 4 19 13 10 0.023
Furosemide 31 13 18* 8* 10* 18* 31 2.0" 11* 23* 20* 13* 0.018*
Values are the means SEM. An asterisk (*) denotes P < 0.05, versus the respective control group.
h SNGFR denotes single nephron filtration rate; APR, absolute proximal reabsorption; LPFR, late proximal tubular flow rate; ALR, absolute
reabsorption at the loop of Henle; DFR, distal tubular flow rate; P1, proximal tubular hydrostatic pressure; IrE, efferent oncotic pressure; irk, renal
interstitial oncotic pressure; FTP, renal interstitial hydrostatic pressure; HPE, efferent arteriolar or large peritubular capillary hydrostatic pressure;
HP5, small peritubular capillary hydrostatic pressure; ERP, mean peritubular capillary effective reabsorptive pressure; and LpAr, peritubular
capillary reabsorptive permeability coefficient.
Determined from subcapsular fluid collections in group 3.
small but significant decrease in pressure at Bowman's space
(PBS), from 13 1 to 11 1 mm Hg after furosemide admin-
istration, this finding did not significantly increase the hydro-
static pressure gradient across glomerular capillaries (P),
which was 35 1 mm Hg in control and 36 1 mm Hg after
furosemide administration. SNGFR decreased significantly in
group 1 after furosemide, and this change was primarily due to
the significant decrease in the single nephron plasma flow
(SNPF). The glomerular permeability coefficient (LA) did not
significantly contribute to the decrease in SNGFR after furo-
semide administration in group 1 because filtration pressure
equilibrium was maintained both in the control period and af-
ter furosemide administration (EFPE 0.2 1.6 in control
and 2.7 2.2 mm Hg after furosemide administration). The de-
crease in SNPF in group 1 was most likely due to the large de-
crease in mean arterial pressure (MAP) after furosemide ad-
ministration (18 4 mm Hg) and not due to alterations in re-
nal vascular resistance (Fig. 3). In group 1, there was no sig-
nificant alteration in afferent or efferent arteriolar resistance or
in post-efferent arteriolar renal vascular resistance (Fig. 3).
In group 2, there was a significant increase in PG following
furosemide administration with urinary replacement (P < 0.02,
Table 3). There was also a significant increase in PBS, which
paralleled the increase in G in group 2 such that P did not
significantly change after furosemide administration (35 I in
control vs. 34 1 mm Hg) (Table 3). There was no significant
U-
z
Cl)
difference in the distal collection determination of SNGFR af-
ter furosemide administration compared to control in group 2.
There was no significant change in either SNPF in group 2 af-
ter furosemide administration (Table 3) or SNBF (Table 1). In
Table 2. Inhibition of tubuloglomerular feedback activity in group 2
rats given furosemide with volume replacement"
DFR LPFR SNGFR SNBF
ni/mm
Control 5 1 15 2 29 3 190 17
Furosemide + vol.
replacement 10 lb 18 2b 31 2 200 15
40
"Values are the means SEM. DFR is distal tubular flow rate; LPFR,
late proximal tubular flow rate; SNGFR, single nephron filtration rate;
and SNBF, single nephron blood flow. Statistical significance is denot-
ed by an asterisk; b P < 0.05.
30
20
10
Distal tubules
40
28±2
30
29±23h±220
10
I 0
Late proximal tubules
40
30
20
10
40
30 31±2
C
20
U-a2
Cl) 10
0
Control Group 1 Group 2
(vol. depletion) (vol. replacement)
Fig. 1. Effect of furosemide administration on SNGFR collected at
early, distal, and late proximal tubule sites. SNGFR decreased (P <
0.05) in both proximal and distally collected sites after furosemide with
3%-body-wt volume depletion (group 1). There was no change in
SNGFR measured from distal tubule collections after furosemide ad-
ministration with volume replacement (group 2). There was also no sig-
nificant change in SNGFR measured from late proximal tubule collec-
tion sites (at lower right).
0
Control
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0
LPFR = 15 1 nI/mm
TLPFR
:'"
::1muh1
All Group 2 Group 1
controls (vol. replacement) (vol. depletion)
Fig. 2. Inhibition of proximal-distal differences in SNGFR following
administration of furosemide. On the basis of measured differences in
proximal and distal SNGFR collections (SNGFR), the mean differ-
ence was significantly greater than zero in the combined control group
(N = 51). There was no significant SNGFR after furosemide with uri-
nary loss replacement (group 2, N = 24) or after furosemide with 3%-
body-wt volume depletion (group 1, N 20). Late proximal tubule
flow rate (LPFR) was not different among the three conditions on an
unpaired basis.
both control and after furosemide administration in group 2,
the condition of filtration pressure equilibrium was maintained
such that changes in L0A could not affect SNGFR. There was
a significant decrease in afferent arteriolar resistance in group
2 (29 2 to 22 3 >< iO dynes sec cm5, P < 0.05). How-
ever, with the lack of a decrease in efferent or post-efferent ar-
teriolar resistance after furosemide administration (Fig. 3), the
total nephron vascular resistance did not change significantly
(52 5 vs. 46 5 x i0 dynes sec cm5, NS).
These data indicate that there were only minor changes in
glomerular dynamics attributable to furosemide administration
and that any reductions in SNGFR are most likely due to
changes in volume status secondary to the diuretic effects of
furosemide. We also observed that there was no total renal
vasodilation in either group I or 2 resulting from furosemide
administration despite the decrease in afferent arteriolar resist-
ance, and that total renal vascular resistances remained high
regardless of volume status.
Effect offurosemide administration on tubular flow rates and
reabsorption. The effect of furosemide in both groups I and 2
on tubular flow rate and forces for reabsorption are shown in
Table 1. In group 1, SNGFR decreased the reduction in abso-
lute proximal reabsorption (APR) (P < 0.01). Despite the sig-
nificant decrease in APR, the reduction in SNGFR was also
sufficient to cause a reduction in late proximal flow rate (LPFR)
(Table 1). However, there was no significant difference in
proximal fractional reabsorption in group 1 (0.46 0.02 in con-
trol vs. 0.51 0.04 after furosemide administration, NS). In
group 1, furosemide administration also resulted in a decrease
in absolute reabsorption from the late proximal collection site
to the distal collection site (ALR) from 9 I to 5 1 nI/mm
(P < 0.01), Distal tubule flow rate (DFR) remained relatively
unchanged in group 1 after furosemide administration (Table
1). Interstitial hydrostatic pressures in group 1 did not change
0
Control Group 2
(vol. replacement)
Fig. 3. Effect of furosemide administration on vascular resistances in
the nephron. in either condition, furosemide with 3%-body-wt volume
depletion (group 1) or furosemide with urinary loss replacement (group
2), there were no significant changes in efferent or post-efferent arte-
riolar resistances compared to the respective control period. There was
a significant decrease in afferent arteriolar resistance in group 2. These
data indicate that furosemide administration did not result in overall
vasodilation in the rat renal vasculature during the measurement pe-
riod, in that total nephron vascular resistance (AR + ER + DR) did
not significantly change.
after furosemide administration and remained at 4 1 mm Hg.
There was no significant alteration in peritubular capillary
hydrostatic pressures after furosemide administration and vol-
ume depletion in group 1 (Table 1). There was also no signifi-
cant change in either the mean effective reabsorption pressure
(ERP) or the glomerular permeability coefficient (L0A) after fu-
rosemide in group 1.
In group 2, which had volume replacement of urinary losses,
furosemide administration did not significantly affect SNGFR
determined from distal collections (Table 1). Also, it did not
significantly decrease the APR. However, there was a small
but significant increase in the LPFR (15 2 to 18 2 nllmin,
P < 0.05), which contributed to the increase in DFR in that
group (Table 1). Also, the ALR decreased significantly from 10
1 (control) to 8 1 nI/mm (P <0.05), which increased the
DFR from 5 I (control) to 10 I ni/mm. In group 3 rats
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Table 3. Effect of furosemide administration on glomerular dynamics in volume-depleted rats (group
-
MAP Pn P13 LP SNGFR SNPF
mm Hg nI/mm
Group I
Control 118 48 13 35 28 90 19
1) and in volume-replaced rats (group 2)
EFP
LA
mm Hg ni sec l mm Hg
35 8 0.06c
±3 ±1 ±1 ±1 ±2 ±17 ±1 l ±1 ±0.01
Furosemide 100* 47 II 36 20* 62* 18 34 10 0.03c
±3 ±1 ±1 ±1 ±1 ±6 ÷1 ±2 ±1 ±0.01
Group 2
Control 114 48 13 35 29 86 17 32 10 0.05"
±3 ±1 ±1 ±1 ±3 ±8 ÷1 ±2 ±1 ±0.01
Furosemide 106 52 18 34 31 90 16 31 10 0.06"
±2 ±2 ±2 ±1 ±2 ±6 ±1 ±2 ±1 ±0.01
Values are the means ± SEM. An asterisk (*) denotes P <0.05, versus the respective control group.
b MAP is mean arterial pressure; P, glomerular capillary hydrostatic pressure; P,S, Bowman's space hydrostatijressure; P, hydrostatic
pressure gradient across glomerular capillaries; SNPF, single nephron plasma flow; ITA, systemic oncotic pressure; EFP, mean effective filtration
pressure; LA, total glomerular permeability. Other abbreviations are defined in Table 1.
Minimum estimate for LA since EFPF is not different from 0.
(which followed the same protocol used for group 2), the in-
terstitial oncotic pressure was 4.6 ± 1.0 in control and 2.0 ±
0.7 mm Hg after furosemide administration (Table 1). Intersti-
tial hydrostatic pressure increased significantly after furose-
mide in group 2 rats, from 4 ± I to 11 ± 2 mmHg (P < 0.01).
There was also an increase in the peritubular capillary hydro-
static pressure at both large and small capillary sites (HPE and
HPs, respectively, Table I). The resulting alteration in hydro-
static pressure gradient after furosemide administration in
group 2 is reflected in a significant increase in ERP from 11 ±
I (control) to 13 ± 2 mm Hg (P <0.05). Since APR was un-
changed after furosemide administration with an increase in
ERP, there was also a significant decrease in LpAr in group 2
(Table 1).
These data indicate that despite marked increases in inter-
stitial hydrostatic pressures after furosemide with volume re-
placement (group 2), there was no change in absolute proximal
reabsorption. Changes in lateral interspace and interstitial ge-
ometry or changes in the transtubular hydrostatic pressure gra-
dient may be required to alter proximal fluid reabsorption. The
reduction in APR in group I with constant interstitial hydro-
static pressure is most likely due to the reduction in SNGFR
caused by the 3% body weight volume depletion and not to a
direct effect of furosemide on proximal tubular transport
mechanisms.
Effect of furosemide with urinary replacement on interstitial
volume. In group 3 rats, subcapsular fluid collections yielded
protein values of 1.7 ± 0.4 g/dl in control and 0.8 ± 0.3 g/dl
after furosemide administration with urinary replacement. Cor-
responding systemic plasma protein values in group 3 were 5.6
± 0.1 (control) and 5.3 ± 0.2 g/dl (after furosemide), values
which were not significantly different. These values yielded ra-
tios of plasma albumin concentration to interstitial albumin
concentration of 2.5:1 (control) and 4.9:1 (after furosemide).
In group 4, blood volume was not significantly different in
the control rats at 11.4 ± 0.1 ml as compared with the furo-
semide rats (11.2 ± 0.5 ml), indicating that the urinary replace-
ment protocol was reasonably accurate in maintaining volume
status. Uncorrected hematocrit was 56 ± 1% (control rats) ver-
sus 57 ± 1% (furosemide + urinary replacement rats). Aver-
age body weight was 235 ± 5 in the control rats and 227 ± 9 g
in furosemide rats (NS). Utilizing the plasma to interstitial
albumin concentration ratio from group 3, group 4 interstitial
volume index was 12.1 ± 0.8% of wet renal cortical tissue wt
in the control group versus 19.6 ± 1.2% after furosemide ad-
ministration with urinary replacement. Interstitial volume in-
dex was significantly increased after furosemide administra-
tion (P < 0.01). Since albumin does not distribute homoge-
neously throughout interstitial and basolateral spaces, these
values can only be utilized as an approximation of interstitial
volume.
The results from groups 3 and 4 indicate change in the vol-
ume of renal interstitial space after furosemide administration
with urinary replacement. With significant increases occurring
in both the interstitial hydrostatic pressure and the renal inter-
stitial volume, it is interesting to note that there was no ob-
served effect on the APR.
Discussion
The results of this investigation address several issues relat-
ing to the regulation of nephron filtration rate and proximal tu-
bule reabsorption during furosemide administration both with
volume depletion and complete replacement of urinary losses.
We have shown that the systemic administration of furose-
mide in both conditions of volume status inhibits what is typi-
cally considered a tubuloglomerular feedback response [32—35].
The predicted concentration of furosemide achieved with this
dose of diuretic (>l0 M)' approaches levels considered to be
inhibitory to tubuloglomerular feedback [1, 351, and it exceeds
the dose used in a study by Burg et al [37] in which a decrease
'This dose is approximated, initiating with the bolus dose (4 mg/kg,
mol wt — 331 g/mole, or 1.2 x 10 moles/kg). If furosemide distnb-
utes homogeneously over 70% of the rat's body space, then this would
result in a furosemide concentration of 1.7 x 10 moles/liter. If there
is no furosemide reabsorption in the proximal tubule, then the concen-
tration of furosemide could increase to greater than 4 x l0
moles/liter, The concentration would further increase to the extent that
furosemide would be secreted into the lumen.
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in sodium and chloride transport in the thick ascending limb
was demonstrated.
In our study there are two lines of evidence suggesting that
furosemide inhibited tubuloglomerular feedback activity. First,
the difference in SNGFR observed between collections ob-
tained in late proximal and early distal tubules disappeared af-
ter furosemide administration. Although there may be techni-
cal reasons for the proximal-distal SNGFR difference, as well
as reasons based on tubuloglomerular feedback mechanisms,
the values for total kidney GFR paralleled the changes in
values for SNGFR obtained in distal tubule collections, sug-
gesting that these values are more accurate than are those ob-
tained from proximal collections. Second, despite the large
increases that occurred in the early distal tubular flow rate dur-
ing furosemide administration, the SNGFR and the renal vas-
cular resistance were not significantly altered, suggesting a dis-
sociation of the normal inverse relation between early distal
flow rate and nephron filtration rate.
If the tubuloglomerular feedback mechanism is a system that
acts to preserve volume homeostasis and is associated with
vasoconstriction when activated [38, 39], then one would ex-
pect that inhibition of the feedback mechanism by furosemide
should have been associated with increases in nephron filtra-
tion rate (as evidenced from distal tubule collections) and in re-
nal vasodilation. No significant change in SNGFR or total
nephron vascular resistance was documented.
A decrease in afferent arteriolar resistance was observed in
the current study, but total nephron vascular resistance was
not significantly decreased. SNGFR did not increase because
nephron plasma flow did not increase, and the rise in PG that
resulted from the decrease in afferent arteriolar resistance was
essentially neutralized by a parallel rise in the Bowman's space
pressure in group 2. These observations reaffirm the complex
nature of the interaction between the several determinants of
glomerular ultrafiltration. Because the data on whole-kidney
GFR paralleled observations from distal tubular collections in
superficial nephrons, it is likely that these data reflect changes
in all nephrons after furosemide administration. Duchin, Pe-
terson, and Burke [7] did document early decreases in total re-
nal vascular resistance after furosemide, but the resistances re-
turned to control values within 60 mm, suggesting that changes
in resistances other than the afferent arteriole may be tran-
sient. In our study, none of the individual vascular resistances
were altered after furosemide administration in group 1, in
which urinary volume losses were not completely replaced.
This constancy of renal vascular resistances in group I despite
an 18-mm Hg decrease in mean arterial pressure may have oc-
curred as a result of increased adrenergic and angiotensin II ac-
tivity in response to the acute volume depletion. Therefore, de-
spite evidence that furosemide inhibited tubuloglomerular feed-
back activity, the reduction in afferent arteriolar resistance in
group 2 rats was the only significant alteration in renal vascu-
lar resistance that was observed. These observations only fur-
ther reinforce the belief that there are several other factors
apart from the tubuloglomerular feedback system that influ-
ence the net renal vascular resistance.
A separate but interesting finding of this study was the ab-
sence of any effect of furosemide on absolute proximal reab-
sorption despite two factors that should decrease APR: (1)
large increases in renal interstitial hydrostatic pressure and (2)
the modest effect of this agent as a carbonic anhydrase inhibi-
tor [9, 10]. Alteration in renal interstitial pressure has been pos-
tulated as a major regulator of change in proximal tubular flow
reabsorption [21, 40-42]. Usually these changes in net renal in-
terstitial pressure occur as a consequence of alterations in pen-
tubular oncotic and hydrostatic pressures. However, in vol-
ume-replete rats (group 2) the interstitial hydrostatic pressure
increased from 4 to 11 mm Hg during furosemide administra-
tion without a significant change in APR. Renal interstitial on-
cotic pressure did not compensate for the increase in intersti-
tial hydrostatic pressure, which was 4.6 1.0 in control and
2.0 0.7 mm Hg after furosemide. Interstitial oncotic and
hydrostatic pressure should have acted in concert and pro-
duced a reduction in APR. One other factor contributing to net
renal interstitial pressure that is not readily evaluated is the
contribution of mucopolysacchanides in the interstitium.
Changes in mucopolysaccharide should parallel changes in inj
(renal interstitial oncotic pressure), but because the interstitial
volume index increased from 12 to 19%, presumably the total
mucopolysaccharide content was unchanged. The fact that net
renal interstitial pressure (irk — HP1) decreased by 9 mm Hg
and that APR was unchanged after furosemide suggests that in-
terstitial forces alone do not exert the primary influence in
changing APR.
Although the changes in renal interstitial pressures after fu-
rosemide do not correlate with any changes in APR, the con-
stancy of APR might have been explained by the parallel in-
creases in HP1 and tubular pressure that were observed, main-
taining a constant hydrostatic pressure gradient across the
proximal tubule epithelium. However, other studies [17, 18, 40,
42] have not revealed any consistent correlation between
changes in the transepithelial hydrostatic pressure gradient and
APR. Although LpAr decreased after furosemide administra-
tion, this finding should result only in a relatively higher value
for HP, and a lower value for iT1and would not explain the con-
stancy of APR. Despite significant evidence that peritubular
physical factors and renal interstitial pressure are modifiers of
APR [21, 41, 43—46], there was no evidence for an alteration in
APR after furosemide administration despite large changes
in penitubular capillary hydrostatic and renal interstitial
pressures.
It is possible that prior correlation of changes in renal inter-
stitial pressure and APR may not have been mediated by pres-
sure alone but by secondary alterations in interstitial space ar-
chitecture and volume (especially at the basolateral aspect of
the proximal tubule). Measurements in control hydropenic rats
revealed that the index of interstitial volume was 12.1 0.8%
of wet renal cortical tissue weight. This value corresponds
quite closely to values for renal interstitial volume determined
from indicator dilution curves of '251-albumin and 5tCr-EDTA
by Larsson, Sjoquist, and Wolgast [47]. These authors deter-
mined that the interstitial volume was 13.1% of total kidney
volume in hydropenia [42, 47]. Although our methods differed
significantly from theirs, the values are remarkably similar. Af-
ter furosemide administration with maintenance of volume
(group 2), the index of interstitial volume increased to 19.2
1.2% (P < 0.01). Whether total interstitial space (basolateral
and true interstitium) increased by this amount cannot be ac-
curately determined in the present study. These measurements
are potentially flawed because albumin is probably not homo-
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geneously distributed between these two compartments. Stud-
ies by Tisher and Kokko [481 have shown that albumin con-
centration is probably not equal within the true interstitium
compared to the basolateral space. This heterogeneity of albu
mm distribution could contribute to inaccuracies if the relative
volumes of these compartments change between control pe-
riod and during furosemide administration. These measure-
ments do indicate that renal interstitial volume did not de-
crease during furosemide administration, suggesting no contri-
bution of alterations in interstitial volume to the APR.
Summary. (1) Furosemide administration resulted in no
change in GFR despite large increases in distal tubular flow
rate, suggesting either an inhibition or reduction in tubulo-
glomerular feedback activity. (2) Even though there was evi-
dence for the inhibition of feedback activity, only afferent ar-
teriolar resistance decreased in group 2 and there was no
change in total nephron vascular resistance in group 2. Also,
nephron filtration rate did not increase within this period of ob-
servation, and total nephron vascular resistance did not signifi-
cantly change regardless of volume status. (3) Despite large in-
creases in renal interstitial hydrostatic pressure during furose-
mide administration, there was no alteration in the absolute
proximal tubular reabsorptive rate. Therefore, although there
were logical theoretical predictions that GFR should increase
and proximal tubular reabsorption decrease with furosemide,
no change in either entity was observed.
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